KAY AZZARA: Open Payments
NPI 1255574026 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 39 payments from 15 companies in 2025. Trend: 2023 $1,431 · 2024 $1,956 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4 | $265 |
| Janssen Biotech, Inc. | 7 | $186 |
| ABBVIE INC. | 4 | $104 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| Amgen Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $50 |
| PFIZER INC. | 2 | $45 |
| Botanix SB Inc | 2 | $44 |
| Incyte Corporation | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
Products named: Zoryve, TREMFYA, LIBTAYO, SKYRIZI, OTEZLA, TALTZ, SOFDRA, OPZELURA.
Industry payments across NY — which companies pay providers there.
